Anderson Hoagland & Co’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-39,985
Closed -$2.32M 126
2023
Q1
$2.32M Sell
39,985
-183
-0.5% -$12.4K 0.33% 80
2022
Q4
$2.79M Sell
40,168
-2,342
-6% -$168K 0.41% 71
2022
Q3
$2.58M Buy
42,510
+543
+1% +$34.7K 0.41% 66
2022
Q2
$2.65M Sell
41,967
-108
-0.3% -$7.15K 0.4% 63
2022
Q1
$2.96M Sell
42,075
-1,076
-2% -$72.7K 0.38% 63
2021
Q4
$2.82M Buy
43,151
+521
+1% +$32.7K 0.37% 69
2021
Q3
$2.63M Buy
42,630
+1,105
+3% +$66.5K 0.34% 71
2021
Q2
$2.48M Buy
41,525
+773
+2% +$49K 0.32% 76
2021
Q1
$2.48M Buy
+40,752
New +$2.25M 0.35% 71

Other funds holding MET

Anderson Hoagland & Co's MET Position: Q2 2023 in Review

Anderson Hoagland & Co sold out of MetLife (MET) in Q2 2023, closing a stake of 39,985 shares — an estimated $2.32M sold.

Anderson Hoagland & Co first reported a position in MET in Q1 2021 and held it in 9 quarters. The position peaked at $2.96M in Q1 2022. 1,170 funds tracked by Wall St. Rank hold MET as of Q2 2023.

  • Anderson Hoagland & Co reported no remaining MetLife position as of Q2 2023 after selling out during the quarter.
  • Anderson Hoagland & Co sold 39,985 MetLife shares in Q2 2023, an estimated $2.32M.
  • Anderson Hoagland & Co first reported a position in MetLife in Q1 2021 and held it in 9 quarters.
  • Anderson Hoagland & Co's MetLife position peaked at $2.96M in Q1 2022.
  • 1,170 funds tracked by Wall St. Rank held MetLife as of Q2 2023.

Based on Anderson Hoagland & Co's 13F filing for Q2 2023, filed 7 Jul 2023.